DR Andlauer
The computed 12-month bankruptcy probability of DR Andlauer is 0.2% (very low). The 2024 annual accounts show equity of €400k and a net result of €194k. Equity is growing by ~26.6% per year across the filed fiscal years. Its solvency ranks better than 59% of 6570 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €400k |
| Net result | €194k |
| Better than sector | 59% |
| Active | 5 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 73.7% | 66.7% | |
| Net result | €194k | €46k | |
| Equity | €400k | €79k | |
| Gross operating margin | €266k | €78k | |
| Total assets | €543k | €154k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €266k |
| Net profit | €194k |
| Cash flow | €214k |
| Staff costs | - |
| Income taxes | €60k |
| Dividends | €297k |
| Total assets | €543k |
| Equity | €400k |
| Debt | €143k |
| of which ≤ 1y | €138k |
| of which > 1y | €5k |
| Working capital | €340k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 3.47 |
| Quick ratio | 3.47 |
| Working capital ratio | 62.5% |
| Solvency | 73.7% |
| Debt / equity | 0.36 |
| Long-term debt ratio | 0.01 |
| Interest coverage | 361.91 |
| Gross margin | - |
| Net margin | - |
| ROA | 35.7% |
| ROE | 48.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €543k |
| Fixed assets | 21/28 | €66k |
| Tangible fixed assets | 22/27 | €66k |
| Current assets | 29/58 | €477k |
| Investments | 50/53 | €333k |
| Cash & bank | 54/58 | €36k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €543k |
| Equity | 10/15 | €400k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €398k |
| Amounts payable | 17/49 | €143k |
| Amounts payable after one year | 17 | €5k |
| Amounts payable within one year | 42/48 | €138k |
| Trade debts payable within one year | 44 | €606 |
| Income statement | ||
| Gross operating margin | 9900 | €266k |
| Operating result | 9901 | €245k |
| Financial income | 75 | €9k |
| Financial charges | 65 | €734 |
| Result before taxes | 9903 | €253k |
| Income taxes | 67/77 | €60k |
| Net result for the period | 9904 | €194k |
| Result to be appropriated | 9905 | €194k |
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 27-01-2021 |
| Status | Active |
| Postal code | 1640 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25744E1088/00A000 | Wallonia | 1.9 ha | 1 · 8,394 m² | 33.6 m · 6 fl. |
| 22004D0121/00H000 | Flanders | 630 m² | 1 · 146 m² | 6.3 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
23-03-2023 Registered office moved from Watermael-Boitsfort to Rhode-Saint-Genèse
- 1170 Watermael-Boitsfort, Rue des Pêcheries 81 bte 18 → 1640 Rhode-Saint-Genèse, Rue Tenbroek 17
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "1640 Rhode-Saint-Gen\u00E8se, Rue Tenbroek 17",
"city": "Rhode-Saint-Gen\u00E8se",
"region": "vlaams_gewest",
"street": "Rue Tenbroek",
"country": "BE",
"postcode": "1640",
"box_number": null,
"street_number": "17",
"locality_suffix": null
},
"old_address": {
"raw": "1170 Watermael-Boitsfort, Rue des P\u00EAcheries 81 bte 18",
"city": "Watermael-Boitsfort",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Rue des P\u00EAcheries",
"country": "BE",
"postcode": "1170",
"box_number": "18",
"street_number": "81",
"locality_suffix": null
},
"effective_date": null,
"evidence_quote": "II r\u00E9sulte d\u0027un acte re\u00E7u par le notaire Philippe Vernimmen, \u00E0 Rhode-Saint-Gen\u00E8se, le neuf mars deux mille vingt-trois, en cours d\u0027enregistrement, que s\u0027est r\u00E9unie l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e DR Andlauer, dont le si\u00E8ge social est \u00E9tabli",
"region_changed": true,
"is_statute_change": true,
"nationality_change": true,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "not_specified",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": true,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Philippe Vernimmen",
"firm_city": null,
"firm_name": null,
"office_city": "Rhode-Saint-Gen\u00E8se",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-03-23",
"filing_date": "2023-03-15",
"act_kind_objet": "AGE-TRANSFERT SIEGE - MODIFICATIONS DES STATUTS"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2023-03-09",
"unanimous": null
},
"subject_company": {
"kbo": "0762.568.963",
"name_full": "DR Andlauer",
"legal_form": "sarl"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Philippe Vernimmen",
"org_rep_person_name": null,
"person_role_at_subject": "notaire"
},
"co_filed_documents": [
"exp\u00E9dition de l\u0027acte"
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | DR Andlauer |